SCHEMBL20350877

SCHEMBL20350877

Cc1cccc(-c2cc(=O)[nH]c(SCc3cccc(C4=NNNN4)c3)c2C#N)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BRD4 O60885 1/20 0.40
▸ MAPT P10636 2/20 0.40
▸ KDM4E B2RXH2 3/20 0.39
▸ TSHR P16473 1/20 0.39
▸ GFER P55789 1/20 0.39
▸ ADORA2A P29274 2/20 0.38
▸ ADORA1 P30542 2/20 0.38
▸ ACMSD Q8TDX5 3/20 0.38
▸ KMT2A Q03164 5/20 0.38
▸ MEN1 O00255 4/20 0.38
▸ POLB P06746 4/20 0.38
▸ CXCR2 P25025 1/20 0.37
▸ ALDH1A1 P00352 4/20 0.37
▸ HPGD P15428 2/20 0.37
▸ ADORA2B P29275 1/20 0.37
▸ TNF P01375 1/20 0.36
▸ PLA2G1B P04054 1/20 0.36
▸ NOD2 Q9HC29 1/20 0.36
▸ NOD1 Q9Y239 1/20 0.36
▸ ATG4B Q9Y4P1 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20351069 0.83 KMT2A (0.40) MAPTKDM4ETSHRGFERACMSD
SCHEMBL20339819 0.80 BRD4 (0.40) BRD4MAPTKDM4ETSHRGFER
SCHEMBL20339967 0.79 ACMSD (0.58) ADORA2AADORA1ACMSDKMT2AMEN1
SCHEMBL20350868 0.74 ACMSD (0.42) BRD4MAPTKDM4ETSHRGFER
SCHEMBL26847198 0.73 KMT2A (0.45) KDM4ETSHRGFERACMSDKMT2A
SCHEMBL20350857 0.72 ACMSD (0.56) ADORA2AADORA1ACMSDKMT2AMEN1
SCHEMBL26847367 0.72 KMT2A (0.40) KDM4ETSHRGFERACMSDKMT2A
SCHEMBL20340155 0.71 ACMSD (0.59) TSHRADORA2AADORA1ACMSDKMT2A
SCHEMBL18455367 0.70 NISCH (0.49) TSHRKMT2AMEN1ALDH1A1HPGD
SCHEMBL24087882 0.70 ACMSD (0.55) KDM4ETSHRGFERACMSDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018125983-A1 OXOPYRIDINE DERIVATIVES USEFUL AS AMINOCARBOXYMUCONATE SEMIALDEHYDE DECARBOXYLASE (ACMSD) INHIBITORS MITOBRIDGE, INC. (US) 2018-07-05 — — WO disclosed
Send feedback